Hello, Fool! | Login | Signup | My Fool
Sep 7, 2008 2:43 AM ET | Site Changes | Help
A global pharmaceutical company, which develops, produces and markets generic drugs covering all major treatment categories.
View Ticker Page (TEVA)
Results 21 - 30 of 216 : 12345Next »
Recs
shpringimbet (74.13) Submitted: 4/10/07 2:17 PM : Start Price: $37.41 TEVA Score: 41.13
Solid company with several important drugs in the pipeline
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
hypersony (33.00) Submitted: 8/30/06 1:16 PM : Start Price: $34.17 TEVA Score: 44.11
unlimited potential
GreenhavenFool (< 20) Submitted: 11/16/06 2:24 PM : Start Price: $30.56 TEVA Score: 67.29
generic drugs will continue to grow with aging population and improving gov benefits under the democrats
coalcentury7 (92.73) Submitted: 11/15/06 11:31 AM : Start Price: $30.29 TEVA Score: 68.09
generics will have a great future or a good future, either way money is made. Solid best of breed large cap in an industry whose growth wont be stopped by a weakning economy. As a less important sidenote, teva is likely to gain if the democrats get a...
dwot (99.99) Submitted: 3/28/07 12:11 PM : Start Price: $36.06 TEVA Score: -44.27
$28 billion market cap and a P/E of 53 and reduced profitability over the past year...No thank you.
techiesense (79.74) Submitted: 8/18/07 6:28 AM : Start Price: $41.17 TEVA Score: 29.82
one of the best pharma values that is well undervalued presently.
wildtribe (< 20) Submitted: 2/12/08 10:24 AM : Start Price: $46.42 TEVA Score: 10.76
This is a growth stock for any occasion but especially in an election year. Generic drugs are the only drugs that Democrats like and TEVA is a great play on the U.S. election where they benefit from being the right type of company at the right time...
K2Vancouver (85.62) Submitted: 1/13/07 11:17 PM : Start Price: $31.54 TEVA Score: 63.69
S&P 2007 Target $38, 3 starsA leader in the highly fragmented generic drug market, with an expanding product line and geographic diversity with low-cost production. Profit progress is strong, but unsteady, given intense competition, as well as ch...
Wicon (82.41) Submitted: 1/19/07 4:37 PM : Start Price: $33.76 TEVA Score: 53.91
The company has a leadership position in the generic pharma industry, which is likely to boom considering the prospects of rising healthcare costs and the need by countries to control it.TEVA is also developing a pipeline of innovative products tha...
msjs1228 (46.26) Submitted: 4/25/07 9:28 PM : Start Price: $37.40 TEVA Score: 43.94
This generic pharma has the most NDA application to the FDA, and has the most rate of approvals. This company will dominate the generic drug business for a long time.